No. |
Chromosome Location |
Chromatin state |
Cell line |
Tissue |
1 |
chr14:105390800-105393600 |
Flanking Active TSS |
Primary hematopoietic stem cells short term culture |
blood
|
2 |
chr14:105390800-105393600 |
Flanking Active TSS |
Primary hematopoietic stem cells G-CSF-mobilized Male |
--
|
3 |
chr14:105390800-105393600 |
Flanking Active TSS |
GM12878-XiMat |
blood
|
4 |
chr14:105390800-105393600 |
Flanking Active TSS |
Monocytes-CD14+_RO01746 |
blood
|
5 |
chr14:105390800-105394000 |
Flanking Active TSS |
Primary B cells from cord blood |
blood
|
6 |
chr14:105391000-105394000 |
Weak transcription |
Stomach Smooth Muscle |
stomach
|
7 |
chr14:105391000-105395400 |
Enhancers |
H1 Derived Mesenchymal Stem Cells |
ES cell derived
|
8 |
chr14:105391200-105393600 |
Flanking Active TSS |
Primary B cells from peripheral blood |
blood
|
9 |
chr14:105391200-105393600 |
Enhancers |
Adipose Nuclei |
Adipose
|
10 |
chr14:105391200-105393600 |
Active TSS |
Brain Hippocampus Middle |
brain
|
11 |
chr14:105391200-105394200 |
Bivalent Enhancer |
Fetal Muscle Trunk |
muscle
|
12 |
chr14:105391600-105394200 |
Enhancers |
Fetal Thymus |
thymus
|
13 |
chr14:105391600-105395000 |
Enhancers |
Fetal Intestine Small |
intestine
|
14 |
chr14:105391600-105398600 |
Weak transcription |
Gastric |
stomach
|
15 |
chr14:105391800-105394200 |
Enhancers |
Spleen |
Spleen
|
16 |
chr14:105392200-105394200 |
Enhancers |
Fetal Muscle Leg |
muscle
|
17 |
chr14:105392200-105395800 |
Genic enhancers |
iPS DF 19.11 Cell Line |
embryonic stem cell
|
18 |
chr14:105392600-105393600 |
Bivalent Enhancer |
Skeletal Muscle Female |
skeletal muscle
|
19 |
chr14:105392600-105393800 |
Weak transcription |
Fetal Intestine Large |
intestine
|
20 |
chr14:105392600-105394400 |
Enhancers |
Primary monocytes fromperipheralblood |
blood
|
21 |
chr14:105392600-105394600 |
Enhancers |
ES-UCSF4 Cell Line |
embryonic stem cell
|
22 |
chr14:105392800-105393400 |
Flanking Active TSS |
Primary hematopoietic stem cells G-CSF-mobilized Female |
--
|
23 |
chr14:105392800-105393600 |
Enhancers |
Placenta |
Placenta
|
24 |
chr14:105392800-105393800 |
Weak transcription |
hESC Derived CD56+ Ectoderm Cultured Cells |
ES cell derived
|
25 |
chr14:105392800-105393800 |
Weak transcription |
iPS DF 6.9 Cell Line |
embryonic stem cell
|
26 |
chr14:105393000-105393600 |
Bivalent Enhancer |
H9 Derived Neuronal Progenitor Cultured Cells |
ES cell derived
|
27 |
chr14:105393000-105393600 |
Bivalent Enhancer |
Foreskin Fibroblast Primary Cells skin02 |
Skin
|
28 |
chr14:105393000-105394200 |
Enhancers |
Rectal Mucosa Donor 29 |
rectum
|
29 |
chr14:105393200-105393400 |
Bivalent Enhancer |
Primary T cells fromperipheralblood |
blood
|
30 |
chr14:105393200-105393400 |
Flanking Active TSS |
Duodenum Mucosa |
Duodenum
|
31 |
chr14:105393200-105393600 |
Flanking Active TSS |
Primary Natural Killer cells fromperipheralblood |
blood
|
32 |
chr14:105393200-105393600 |
Enhancers |
Sigmoid Colon |
Sigmoid Colon
|
33 |
chr14:105393200-105394000 |
Enhancers |
Esophagus |
oesophagus
|
34 |
chr14:105393200-105394200 |
Enhancers |
Primary hematopoietic stem cells |
blood
|